Biotage Ab Stock Buy Hold or Sell Recommendation
| BITGF Stock | USD 16.87 0.00 0.00% |
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding Biotage AB is 'Hold'. Macroaxis provides Biotage AB buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding BITGF positions. The advice algorithm takes into account all of Biotage AB's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Biotage AB's buy or sell advice are summarized below:
Real Value 15.65 | Hype Value 16.87 | Market Value 16.87 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Biotage AB given historical horizon and risk tolerance towards Biotage AB. When Macroaxis issues a 'buy' or 'sell' recommendation for Biotage AB, the advice is generated through an automated system that utilizes algorithms and statistical models.
Biotage |
Execute Biotage AB Buy or Sell Advice
The Biotage recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Biotage AB. Macroaxis does not own or have any residual interests in Biotage AB or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Biotage AB's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Hold
Market Performance | OK | Details | |
Volatility | Somewhat reliable | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Biotage AB Trading Alerts and Improvement Suggestions
| Biotage AB is way too risky over 90 days horizon | |
| Biotage AB appears to be risky and price may revert if volatility continues | |
| About 65.0% of the company shares are held by institutions such as insurance companies |
Biotage AB Returns Distribution Density
The distribution of Biotage AB's historical returns is an attempt to chart the uncertainty of Biotage AB's future price movements. The chart of the probability distribution of Biotage AB daily returns describes the distribution of returns around its average expected value. We use Biotage AB price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Biotage AB returns is essential to provide solid investment advice for Biotage AB.
| Mean Return | 0.61 | Value At Risk | 0.00 | Potential Upside | 0.00 | Standard Deviation | 5.00 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Biotage AB historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Biotage AB Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Biotage AB or Biotage sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Biotage AB's price will be affected by overall otc stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Biotage otc's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | 0.63 | |
β | Beta against NYSE Composite | -0.31 | |
σ | Overall volatility | 5.11 | |
Ir | Information ratio | 0.11 |
Biotage AB Volatility Alert
Biotage AB exhibits very low volatility with skewness of 8.12 and kurtosis of 66.0. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Biotage AB's otc stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Biotage AB's otc stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Biotage AB Fundamentals Vs Peers
Comparing Biotage AB's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Biotage AB's direct or indirect competition across all of the common fundamentals between Biotage AB and the related equities. This way, we can detect undervalued stocks with similar characteristics as Biotage AB or determine the otc stocks which would be an excellent addition to an existing portfolio. Peer analysis of Biotage AB's fundamental indicators could also be used in its relative valuation, which is a method of valuing Biotage AB by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Biotage AB to competition |
| Fundamentals | Biotage AB | Peer Average |
| Return On Equity | 0.18 | -0.31 |
| Return On Asset | 0.11 | -0.14 |
| Profit Margin | 0.16 % | (1.27) % |
| Current Valuation | 1.17 B | 16.62 B |
| Shares Outstanding | 65.98 M | 571.82 M |
| Shares Owned By Insiders | 0.58 % | 10.09 % |
| Shares Owned By Institutions | 64.57 % | 39.21 % |
| Price To Earning | 47.58 X | 28.72 X |
| Price To Book | 6.36 X | 9.51 X |
| Price To Sales | 6.61 X | 11.42 X |
| Revenue | 1.23 B | 9.43 B |
| Gross Profit | 755 M | 27.38 B |
| EBITDA | 347 M | 3.9 B |
| Net Income | 205 M | 570.98 M |
| Cash And Equivalents | 15.1 M | 2.7 B |
| Cash Per Share | 0.23 X | 5.01 X |
| Total Debt | 150 M | 5.32 B |
| Debt To Equity | 0.16 % | 48.70 % |
| Current Ratio | 2.43 X | 2.16 X |
| Book Value Per Share | 1.17 X | 1.93 K |
| Cash Flow From Operations | 353 M | 971.22 M |
| Earnings Per Share | 0.35 X | 3.12 X |
| Number Of Employees | 510 | 18.84 K |
| Beta | 0.81 | -0.15 |
| Market Capitalization | 1.12 B | 19.03 B |
| Total Asset | 1.99 B | 29.47 B |
| Retained Earnings | 541 M | 9.33 B |
| Working Capital | 212 M | 1.48 B |
| Current Asset | 327 M | 9.34 B |
| Current Liabilities | 115 M | 7.9 B |
| Z Score | 4.2 | 8.72 |
| Annual Yield | 0.01 % | |
| Net Asset | 1.99 B |
Biotage AB Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Biotage . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Biotage AB Buy or Sell Advice
When is the right time to buy or sell Biotage AB? Buying financial instruments such as Biotage OTC Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Biotage AB in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Recycling Thematic Idea Now
Recycling
West management companies as well as entities specializing in pollution control and recycling. The Recycling theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Recycling Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Biotage AB Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the Biotage AB information on this page should be used as a complementary analysis to other Biotage AB's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Complementary Tools for Biotage OTC Stock analysis
When running Biotage AB's price analysis, check to measure Biotage AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotage AB is operating at the current time. Most of Biotage AB's value examination focuses on studying past and present price action to predict the probability of Biotage AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotage AB's price. Additionally, you may evaluate how the addition of Biotage AB to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| CEOs Directory Screen CEOs from public companies around the world |